VIYASH SCIENTIFIC LIMITED

BSE: VIYASH512529ISIN INE807F01027

Healthcare
Pharmaceuticals
BSE 1000

Share price

₹228.55+9.05 (+4.12%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹297.90
52W low: ₹178.40
Off 52W high: -23.28%
1M return: -0.31%
3M return: -16.45%
6M return: +4.05%
1Y return: +4.34%
20D avg volume: 1,97,475
50 DMA: ₹241.43
200 DMA: ₹233.78

Key ratios Consolidated

Market cap: ₹10,097 Cr
Current price: ₹228.55
52W high / low: ₹297.90 / ₹178.40
Face value: ₹2.00
P/E: 47.21
P/B: 3.43
EPS (TTM): ₹4.84
Book value / share: ₹66.64
ROE: —
ROCE: 11.40%
Operating margin: —
Net margin: —
Debt / equity: 0.14
Net debt: ₹180.06 Cr
Interest cover: 6.04
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 133.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	946.36	919.96	858.41	423.99	441.42	401.70	390.81	368.65	390.21	361.20	329.36	345.97
	8.31	15.92	13.98	2.15	3.87	1.66	5.84	4.51	2.68	4.00	4.52	1.65
	954.67	935.88	872.39	426.14	445.29	403.36	396.65	373.16	392.89	365.19	333.88	347.62
	842.26	810.64	758.06	397.28	418.52	386.71	388.24	360.94	380.89	357.85	335.15	358.78
	402.34	363.92	347.29	182.79	179.69	159.00	169.93	135.34	153.10	166.37	145.69	156.62
	65.36	92.01	56.58	45.14	52.10	36.60	41.79	65.96	68.22	41.37	38.22	49.68
	162.65	149.82	137.69	81.69	79.07	76.81	75.22	67.04	62.05	62.19	57.86	66.36
	12.51	14.52	16.75	13.51	14.16	15.13	14.95	14.29	16.38	12.44	12.58	12.58
	61.77	60.41	58.53	15.46	15.13	16.12	16.98	17.10	16.25	16.48	15.46	15.36
	171.08	173.06	154.16	73.52	75.61	78.91	79.10	69.75	71.14	70.21	67.98	72.25
	112.41	125.24	114.33	28.86	26.77	16.65	8.41	12.22	12.00	7.34	-1.27	-11.16
	0.00	0.00	-41.26	-1.70	-1.25	-0.34	-0.31	-4.32	0.00	-4.71	2.76	8.07
	112.41	125.24	73.07	27.16	25.52	16.31	8.10	7.90	12.00	2.64	1.49	-3.09
	33.12	58.86	24.55	7.56	7.95	5.93	1.62	1.56	2.94	1.36	9.19	3.79
	79.29	66.38	48.52	19.60	17.57	10.38	6.48	6.34	9.06	1.27	10.68	-6.88
	1.51	1.20	0.89	0.59	0.57	0.37	0.14	0.10	0.26	-0.04	0.33	-0.34
Key metrics
	186.69	200.17	148.35	56.13	54.81	47.56	40.03	39.29	44.63	31.56	29.53	24.85
	19.70%	21.80%	17.30%	13.20%	12.40%	11.80%	10.20%	10.70%	11.40%	8.70%	9.00%	7.20%
	8.40%	7.20%	5.70%	4.60%	4.00%	2.60%	1.70%	1.70%	2.30%	0.40%	3.20%	-2.00%
	—	3.80%	—	3.30%	—	2.90%	—	—	—	—	—	—
	114.40%	129.00%	119.60%	15.00%	13.10%	11.20%	18.70%	6.60%	—	—	—	—
	351.30%	539.50%	648.80%	209.10%	93.90%	717.30%	-39.30%	192.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Income statement
	3,149	3,420	1,551	1,370	1,421	1,413	1,362	1,179	1,039	849.45	915.08
	40.36	43.55	14.69	10.96	6.39	10.85	8.36	10.09	8.67	16.58	11.07
	3,189	3,464	1,566	1,381	1,427	1,424	1,370	1,189	1,048	866.03	926.16
	2,808	3,071	1,517	1,418	1,500	1,370	1,225	1,095	989.10	840.88	925.52
	1,296	1,377	617.37	613.67	693.10	670.52	588.66	508.69	453.87	344.59	390.14
	259.09	250.59	212.57	175.54	121.77	171.89	145.02	88.89	116.64	141.84	—
	531.85	565.50	281.12	250.57	258.38	231.37	187.22	165.06	145.95	113.83	—
	57.29	69.21	60.75	48.09	35.52	15.77	24.38	35.71	32.80	33.07	36.28
	196.17	233.64	66.45	61.54	55.69	51.09	50.60	50.62	41.92	—	—
	571.82	639.55	296.61	290.18	300.02	279.05	267.67	238.81	225.41	188.54	237.23
	380.84	393.23	49.28	-37.26	-72.86	53.39	145.45	94.08	58.88	25.15	0.64
	-42.96	-44.21	-4.97	-17.39	-64.79	0.00	-8.82	0.00	0.00	-1.50	0.00
	337.88	349.02	44.31	-54.65	-137.66	53.39	136.63	94.08	58.88	23.64	0.64
	124.09	124.37	12.05	25.03	15.68	8.33	32.18	12.03	2.01	13.46	0.41
	213.79	224.65	32.26	-29.61	-121.98	45.06	104.45	82.05	56.88	430.83	-16.39
	4.19	4.09	0.88	-1.44	-4.88	1.67	3.87	2.87	2.00	—	—
Key metrics
	591.34	651.87	171.51	54.98	-46.45	120.25	211.61	180.41	133.60	56.71	36.92
	18.78%	19.10%	11.10%	4.00%	-3.30%	8.50%	15.50%	15.30%	12.90%	6.70%	4.00%
	6.79%	6.60%	2.10%	-2.20%	-8.60%	3.20%	7.70%	7.00%	5.50%	50.70%	-1.80%
	—	11.40%	9.60%	—	—	—	—	—	—	—	—
	96.48%	120.50%	13.30%	-3.60%	0.60%	3.80%	15.50%	13.50%	22.40%	-7.20%	—
	424.38%	596.40%	208.90%	75.70%	-370.70%	-56.90%	27.30%	44.30%	-86.80%	2,728.60%	—
	—	188.19	44.27	—	—	—	—	—	—	—	—
	—	1.44	2.58	—	—	—	—	—	—	—	—
	—	0.14	0.58	—	—	—	—	—	—	—	—
	—	180.06	383.72	—	—	—	—	—	—	—	—
	—	133.5	115.7	—	—	—	—	—	—	—	—
Balance sheet
	—	4,628	1,602	—	—	—	—	—	—	—	—
	—	2,255	872.92	—	—	—	—	—	—	—	—
	—	255.76	62.66	—	—	—	—	—	—	—	—
	—	1,045	363.17	—	—	—	—	—	—	—	—
	—	803.20	385.32	—	—	—	—	—	—	—	—
	—	129.53	53.73	—	—	—	—	—	—	—	—
	—	1,138	231.62	—	—	—	—	—	—	—	—
	—	597.27	256.72	—	—	—	—	—	—	—	—
	—	945.90	505.01	—	—	—	—	—	—	—	—
	—	435.82	446.38	—	—	—	—	—	—	—	—
	—	133.72	172.50	—	—	—	—	—	—	—	—
	—	302.10	273.88	—	—	—	—	—	—	—	—
	—	3,115	770.36	—	—	—	—	—	—	—	—
Cash flow
	—	322.91	83.36	—	—	—	—	—	—	—	—
	—	-84.12	-24.78	—	—	—	—	—	—	—	—
	—	-123.33	-60.73	—	—	—	—	—	—	—	—
	—	134.72	39.09	—	—	—	—	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	353.69	372.49	341.64	34.03	41.07	42.33	36.27	41.99	57.67	36.77	42.20	49.12
	14.59	19.75	16.29	11.75	11.48	12.27	11.88	15.95	10.84	12.97	13.44	9.87
	368.28	392.24	357.93	45.78	52.55	54.60	48.15	57.94	68.51	49.75	55.65	58.98
	340.39	343.49	306.06	39.74	46.52	48.44	44.16	47.21	62.46	45.65	49.56	60.38
	165.31	156.16	155.03	16.80	19.76	21.42	22.55	24.52	18.42	23.68	27.17	23.35
	3.42	18.21	5.44	0.00	0.00	0.00	—	—	10.28	—	—	—
	70.64	57.45	50.10	9.46	9.48	10.58	9.30	8.04	7.13	7.09	7.12	7.22
	1.44	2.53	3.56	0.83	1.08	0.99	1.17	1.00	0.81	1.02	1.15	1.21
	32.41	31.16	31.20	2.24	2.33	2.30	2.24	2.12	2.00	2.11	2.05	2.35
	72.67	82.02	70.39	11.67	12.15	12.28	11.33	10.11	10.84	11.53	11.81	9.50
	27.89	48.75	51.87	6.04	6.03	6.16	3.99	10.73	6.05	4.10	6.09	-1.40
	0.00	0.00	-41.26	-1.70	-1.25	-0.25	-0.31	-4.32	—	—	—	—
	27.89	48.75	10.61	4.34	4.78	5.91	3.68	6.41	6.05	4.10	6.09	-1.40
	6.97	12.94	10.69	1.26	1.41	1.68	0.87	2.15	1.55	0.34	1.51	0.48
	20.92	35.81	-0.08	3.08	3.37	4.23	2.81	4.26	4.50	3.76	4.58	-0.92
	0.48	0.82	0.00	0.12	0.14	0.17	0.11	0.17	0.18	0.15	0.18	-0.04
Key metrics
	61.74	82.44	45.37	7.41	8.19	9.20	7.09	9.53	8.86	7.23	9.29	2.16
	17.50%	22.10%	13.30%	21.80%	19.90%	21.70%	19.50%	22.70%	15.40%	19.70%	22.00%	4.40%
	5.90%	9.60%	0.00%	9.10%	8.20%	10.00%	7.70%	10.10%	7.80%	10.20%	10.90%	-1.90%
	—	1.60%	—	0.40%	—	0.60%	—	—	—	—	—	—
	761.20%	780.00%	841.90%	-19.00%	-28.80%	15.10%	-14.10%	-14.50%	—	—	—	—
	520.80%	746.60%	-102.80%	-27.70%	-25.10%	12.50%	-38.60%	563.00%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Income statement
	1,102	1,382	178.26	168.52	222.69	219.63	265.46	227.33	167.68	107.24	392.21
	62.38	66.26	50.94	45.98	28.24	27.64	19.97	14.56	13.53	24.27	20.09
	1,164	1,448	229.20	214.50	250.93	247.27	285.42	241.89	181.20	131.50	412.31
	1,030	1,288	202.27	208.48	260.67	231.58	241.97	219.08	175.00	129.68	412.32
	493.30	599.82	86.91	102.54	114.07	124.01	115.88	108.69	77.34	30.66	195.37
	27.07	28.41	10.28	—	2.42	4.38	8.54	8.24	20.23	49.14	—
	187.65	213.75	35.05	30.05	36.66	27.38	22.42	17.10	10.97	11.85	—
	8.36	16.21	3.96	4.36	2.51	1.61	2.68	5.04	3.22	0.39	8.36
	97.01	124.15	8.67	8.94	9.12	9.59	9.13	8.95	7.26	3.67	—
	236.75	309.91	49.09	43.91	49.71	46.76	50.13	34.45	27.12	21.41	104.88
	134.55	160.43	26.93	6.01	-9.75	15.69	43.45	22.81	6.20	1.82	-0.01
	-42.96	-44.21	-4.88	-6.25	—	—	-2.56	—	—	-1.16	—
	91.59	116.22	22.05	-0.24	-9.75	15.69	40.89	22.81	6.20	0.66	-0.01
	31.86	40.35	6.25	0.86	3.67	0.89	8.77	1.47	1.38	2.87	—
	59.73	75.87	15.80	0.62	-6.08	14.80	32.11	21.34	7.59	406.41	-0.01
	1.42	1.75	0.63	0.03	-0.24	0.60	1.30	0.88	0.31	—	—
Key metrics
	196.96	256.58	34.68	13.06	1.88	26.89	52.70	36.80	16.68	4.72	8.35
	17.88%	18.60%	19.50%	7.70%	0.80%	12.20%	19.90%	16.20%	9.90%	4.40%	2.10%
	5.42%	5.50%	8.90%	0.40%	-2.70%	6.70%	12.10%	9.40%	4.50%	379.00%	0.00%
	—	4.10%	2.30%	—	—	—	—	—	—	—	—
	581.58%	675.30%	5.80%	-24.30%	1.40%	-17.30%	16.80%	35.60%	56.40%	-72.70%	—
	307.16%	380.20%	2,448.40%	110.20%	-141.10%	-53.90%	50.50%	181.20%	-98.10%	40,64,200.00%	—
	—	18.19	-13.03	—	—	—	—	—	—	—	—
	—	1.57	-0.07	—	—	—	—	—	—	—	—
	—	0.01	0.04	—	—	—	—	—	—	—	—
	—	11.15	44.35	—	—	—	—	—	—	—	—
	—	141.7	145.4	—	—	—	—	—	—	—	—
Balance sheet
	—	3,655	1,222	—	—	—	—	—	—	—	—
	—	962.45	107.52	—	—	—	—	—	—	—	—
	—	20.97	0.03	—	—	—	—	—	—	—	—
	—	554.26	68.93	—	—	—	—	—	—	—	—
	—	292.87	25.05	—	—	—	—	—	—	—	—
	—	79.45	11.95	—	—	—	—	—	—	—	—
	—	802.72	45.47	—	—	—	—	—	—	—	—
	—	310.55	22.93	—	—	—	—	—	—	—	—
	—	415.77	75.56	—	—	—	—	—	—	—	—
	—	32.12	44.38	—	—	—	—	—	—	—	—
	—	25.80	44.38	—	—	—	—	—	—	—	—
	—	6.32	0.00	—	—	—	—	—	—	—	—
	—	3,189	1,143	—	—	—	—	—	—	—	—
Cash flow
	—	119.12	-1.12	—	—	—	—	—	—	—	—
	—	-106.88	-0.44	—	—	—	—	—	—	—	—
	—	-7.06	0.66	—	—	—	—	—	—	—	—
	—	100.93	11.91	—	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +83.77%
Sales CAGR 5Y: +39.09%
Profit CAGR 3Y: —
Profit CAGR 5Y: +18.76%
Sales YoY (TTM): +581.58%
Profit YoY (TTM): +307.16%

Consolidated

Sales CAGR 3Y: +34.02%
Sales CAGR 5Y: +20.23%
Profit CAGR 3Y: —
Profit CAGR 5Y: +16.55%
Sales YoY (TTM): +96.48%
Profit YoY (TTM): +424.38%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 49.24%

Quarter	September 2026	June 2026
Promoter %	49.24%	61.31%

Holder	Type	Holding	Previous	Change
CA HULL INVESTMENTS	Promoter	25.03%	31.17%	-6.14%
CA HARBOR INVESTMENTS	Promoter	24.21%	30.14%	-5.93%
KOTAK CONTRA FUND	Public	4.05%	—	—
HARIBABU BODEPUDI	Public	2.74%	2.77%	-0.03%
KALIDINDI SRIHARI RAJU	Public	2.23%	2.35%	-0.12%
BANDHAN LARGE & MID CAP FUND	Public	1.97%	—	—
NARASIMHA REDDY DUTHALA	Public	1.16%	1.27%	-0.11%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
VIYASH SCIENTIFIC LIMITED	10,097	228.55	47.21	11.40%	+96.48% TTM	+424.38% TTM	+4.34%

Filings & corporate actions

Recent announcements

Allotment of ESOP2 Nov 2026 · Company Update / Allotment of ESOP / ESPS
Intimation of Q2 FY27 Earnings Conference Call / Discussion on Financial Results for Quarter and Half Year Ended September 30, 2026.2 Nov 2026 · Company Update / Analyst / Investor Meet
Viyash Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....2 Nov 2026 · Board Meeting / Board Meeting
Please find enclosed herewith update on the Incorporation of step down Subsidiary in Vietnam.2 Nov 2026 · Company Update / Acquisition
We are enclosing herewith the copy of Newspaper Publications for Special Window for Transfer and Dematerialisation of Physical Securities.22 Oct 2026 · Company Update / Newspaper Publication
Intimation under Reg 30 of SEBI (LODR) 2015 for Change in Senior Management Personnel.20 Oct 2026 · Company Update / Change in Management
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for White Oak Capital Management Consultants LLP17 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Allotment of ESOP8 Oct 2026 · Company Update / Allotment of ESOP / ESPS
Certificate under Re. 74(5) of SEBI (DP) Regulation is enclosed.6 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Completion of acquisition of BioForLife Italia S.r.l.1 Oct 2026 · Company Update / Acquisition
Closure of Trading Window for Q2 FY 2026-2728 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Allotment of ESOP18 Sep 2026 · Company Update / Allotment of ESOP / ESPS
Update on proposed acquisition of BioForLife Italia S.r.l8 Sep 2026 · Company Update / General
Allotment of ESOP4 Sep 2026 · Company Update / Allotment of ESOP / ESPS
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CA Harbor Investment & CA Hull Investments27 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Earning call Transcript Q1 FY 2026-2716 Aug 2026 · Company Update / Earnings Call Transcript
Audio Recording of Earnings call pertaining to the unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 202612 Aug 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication for Financial Results of Q1 FY 27.12 Aug 2026 · Company Update / Newspaper Publication
Investor Presentation Q1 FY 2026-202712 Aug 2026 · Company Update / Investor Presentation
Voting results and scrutinizer Report11 Aug 2026 · AGM/EGM / AGM
Voting results and scrutinizer Report11 Aug 2026 · AGM/EGM / AGM
Outcome of the 41st AGM held on August 11, 202611 Aug 2026 · AGM/EGM / AGM
Press Release for Q1 FY 2026-2711 Aug 2026 · Company Update / Press Release / Media Release
Allotment of ESOP under Viyash Scientific Limited -Employee Stock Option Scheme 202611 Aug 2026 · Company Update / Allotment of ESOP / ESPS
Outcome of Board Meeting11 Aug 2026 · Board Meeting / Outcome of Board Meeting
Unaudited Financial Results for Q1 FY 2026-202711 Aug 2026 · Result / Financial Results
Intimation of Q1 FY27 Earnings Conference Call / Discussion on Financial Results for Quarter Ended June 30, 20263 Aug 2026 · Company Update / Analyst / Investor Meet
Viyash Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Quarterly Results for Q1 FY 2026-273 Aug 2026 · Board Meeting / Board Meeting
ESOP Allotment1 Aug 2026 · Company Update / Allotment of ESOP / ESPS
Intimation under Regulation 30 of SEBI LODR21 Jul 2026 · Company Update / General
41st AGM notice - Newspaper Publication18 Jul 2026 · Company Update / Newspaper Publication
Letter to the shareholders Annual Report FY 2025-2617 Jul 2026 · Company Update / General
Business Responsibility and Sustainability Reporting(BRSR)17 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of 41st Annual General Meeting17 Jul 2026 · AGM/EGM / AGM
Annual Report for FY 2025-2617 Jul 2026 · Others / Reg. 34 (1) Annual Report
Newspaper Publication - AGM Notice14 Jul 2026 · Company Update / Newspaper Publication
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure) Requirements, 2015.7 Jul 2026 · Company Update / General
Certificate under Regulation 74(5) of SEBI(DP)Regulations, 20186 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Postal Ballot Result and Scrutinizer''s Report29 Jun 2026 · AGM/EGM / Postal Ballot
Notice for Closure of Trading window26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window

Board meetings

13 Nov 2026 Board Meeting - Financial Results
11 Aug 2026 Board Meeting - Financial Results